Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
irradiated MMC10-BCSC whole tumor cell vaccine
- Development stage
- Preclinical
- Lead developer
- Cleveland Clinic
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Subcutaneous, Intraperitoneal, Intratumoral
01
Overview
Irradiated MMC10-BCSC whole tumor cell vaccine is an experimental preclinical cancer vaccine derived from breast cancer stem-like cells (BCSC) of the mouse mammary carcinoma (MMC) sub-line MMC10. Developed by researchers at The Cleveland Clinic, the vaccine is designed to stimulate an immune response against HER2/neu-positive breast cancer. In preclinical models, vaccination with irradiated MMC10-BCSCs primes CD4+ and CD8+ T cells, which can be harvested and expanded in vitro to mediate the regression of established pulmonary metastases upon adoptive transfer.
- Other names
- MMC10-BCSC vaccineMMC-10-BCSC vaccineMMC 10-BCSC vaccineirradiated MMC10-BCSC vaccine
02
Targets
CSF2R (Granulocyte-macrophage colony-stimulating factor receptor)ERBB2 (Erb-b2 receptor tyrosine kinase 2)
Beyond the preview
Go deeper on irradiated MMC10-BCSC whole tumor cell vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on irradiated MMC10-BCSC whole tumor cell vaccine.